Vaccine Therapy Plus Sargramostim and Interleukin-2 Compared With Nilutamide Alone in Treating Patients With Prostate Cancer

This study has been completed.

Study NCT00020254 Information provided by National Cancer Institute (NCI)

First Received: July 11, 2001 Last Updated: February 6, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	October 2004 (Final data collection date for primary outcome measure)